Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?

• Hoofdauteurs: Cong Huang (Auteur), Carolina Oi Lam Ung (Auteur), Haishaerjiang Wushouer (Auteur), Lin Bai (Auteur), Tao Huang (Auteur), Xinyi Li (Auteur), Xiaodong Guan (Auteur), Luwen Shi (Auteur)
• Formaat: Boek
• Gepubliceerd in: BMC, 2022-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Background In China, health technology assessment (HTA) has recently been adopted in pricing negotiation for medicine listing in the National Reimbursement Drug List. At present, how HTA is applied to inform the decision-making process remains underreported. In order to explore how the adop...